---
title: 'Senior Manager, Scientific Communications & Medical Education at Rezolute'
canonical: 'https://feeny.ai/job/senior-manager-scientific-communications-medical-education-rezolute-redwood-city-363wemxkxap1'
type: 'job'
last_seen: '2026-11-06'
---

# Senior Manager, Scientific Communications & Medical Education at Rezolute

- **Company:** Rezolute
- **Location:** Redwood City, CA
- **Employment:** full-time
- **Work type:** onsite
- **Posted:** 2026-10-20
- **Last confirmed live:** 2026-11-06
- **Apply:** https://jobs.lever.co/rezolutebio/2378baf6-9a33-4c36-a0ac-6507be649065

## Job description

Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity.

Rezolute’s lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage development for hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI), including congenital hyperinsulinism (cHI), the most common cause of persistent hypoglycemia in infants and children.

The Senior Manager, Scientific Communications & Medical Education will develop and manage Rezolute’s core scientific content and medical review activities for RZ358 across congenital and tumor HI. Key responsibilities include standard response document (SRD) development, in-house Medical Information, medical review in MLR/PRC, medical education grant management, Scientific Communication Platform (SCP) coordination, and MSL slide deck development. The Senior Manager will partner with MSLs, Medical Affairs Core Services, and cross-functional colleagues, and will report to the Director, Scientific Communications & Medical Education.

## Key Responsibilities

- Scientific Content Development

- Develop and maintain standard response documents (SRDs), FAQs, and custom responses for RZ358.
- Coordinate development and updates of the SCP with the Medical Communications vendor and cross-functional teams.
- Develop and maintain MSL scientific slide decks aligned with the SCP and current clinical data.

Medical Information

- Manage in-house Medical Information, providing accurate, balanced responses to unsolicited inquiries from HCPs, patients, and caregivers.
- Partner with Medical Affairs Operations on Medical Information processes, vendor support, and inquiry tracking.
- Identify inquiry trends and share insights with Medical Affairs.

-

MLR Medical Review

- Serve as the Medical Affairs reviewer in MLR/PRC for promotional and non-promotional materials.
- Ensure scientific accuracy, fair balance, and appropriate referencing, consistent with the SCP.

Medical Education Grants

- Manage the medical education grant process, from request intake and review through approval, contracting, and reconciliation.
- Ensure grants are independent, compliant with ACCME standards and company policy, and tracked against budget.

Compliance & Governance

- Ensure activities adhere to Rezolute SOPs, regulatory standards, and industry codes of practice.
- Contribute to SOPs and work instructions for SRDs, Medical Information, and grants.

Partner with pharmacovigilance on reporting of adverse                 events and product complaints received through Medical                 Information

Required Qualifications

- PharmD, PhD, MD, or other advanced scientific degree.
- Hands-on experience developing SRDs and Medical Information responses.
- Experience serving as a Medical Affairs reviewer in MLR/PRC.
- Working knowledge of medical education grant processes, ACCME standards, and applicable industry codes and transparency requirements.
- Ability to translate complex scientific data into clear, accurate, and balanced content.
- Strong project management and attention to detail, with the ability to manage multiple deliverables and vendors.
- Strong communication and collaboration skills in a fast-paced, matrixed organization.
- Willingness to travel domestically (up to approximately 20%).

## Preferred Experience and Attributes

- Minimum of 5 years of Medical Affairs experience in the biopharmaceutical industry, ideally in rare disease, endocrinology, or metabolic disease.
- Experience supporting rare disease or pediatric product launches.
- Experience with Veeva Vault PromoMats and Medical Information systems.
- Experience working with Medical Communications agencies and Medical Information vendors.
- High integrity, accountability, and commitment to Rezolute’s mission.

Rezolute (RZLT) currently anticipates the base salary for Senior Manager, Scientific Communications & Medical Education role could range from $180,000 to $225,000 and will depend, in part, on the successful candidate’s geographical location and their qualifications for the role, including education and experience. This position will also be eligible for an annual performance bonus in accordance with the terms of the applicable plan (depending, in part, on company and individual performance and at the Company’s discretion on an individual basis). The compensation described above is subject to change and could be higher or lower than the range described based on current market survey data and the qualifications, education, experience and geographical location of the selected candidate. Rezolute offers competitive compensation, stock options and a rich benefits package.

Qualifying employees are eligible to participate in benefit programs such as: Health Insurance (Medical / Dental / Vision) Disability, Life & Long-Term Care Insurance Holiday Pay Tracking Free Vacation Program 401(k) Plan Match Educational Assistance Benefit Fitness Center Reimbursement

We are an Equal Opportunity Employer and do not discriminate against applicants due to race, ethnicity, gender, veteran status, or on the basis of disability or any other federal, state or local protected class.

## About Rezolute

## Company Overview
- **One-liner**: Rezolute is a late-stage rare disease biotechnology company developing ersodetug, a monoclonal antibody therapy for hypoglycemia caused by congenital and tumor hyperinsulinism.
- **Entity Type**: Public (Nasdaq: RZLT)
- **Headquarters**: Redwood City, California, United States (with an additional office in Louisville)
- **Founded**: Not publicly available (IPO 2012)
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology – rare disease therapeutics
- **Target customers**: B2B – healthcare providers, patients, and payers; focuses on addressing severe unmet medical needs in hyperinsulinism
- **Mission/purpose**: Significantly improve outcomes for individuals with hypoglycemia caused by hyperinsulinism ([rezolutebio.com – About](https://rezolutebio.com/job-openings/))

## Products & Services
- **Ersodetug (lead candidate)**: An intravenously administered human monoclonal antibody that allosterically binds to the insulin receptor, down‑modulating insulin action to restore normal glucose levels. Being developed for two indications:
  - **Congenital Hyperinsulinism (sunRIZE Phase 3 study)** – completed enrollment (May 2025) with 62 participants; topline results expected December 2025.
  - **Tumor Hyperinsulinism (upLIFT Phase 3 study)** – initiated mid‑2025; FDA agreed to a single‑arm open‑label design; topline results expected second half 2026.
  - Designations: Orphan Drug (US/EU), Rare Pediatric Disease, Breakthrough Therapy (US), PRIME (EU), ILAP (UK) ([ir.rezolutebio.com – 10-K](https://ir.rezolutebio.com/sec-filings/content/0001104659-25-090848/0001104659-25-090848.pdf))

## Market Standing
- **Valuation/Market Cap**: $317.7 million (as of recent data, per LinkedIn) ([linkedin.com](https://linkedin.com/company/rezolute))
- **Key Metric (Public)**: Annual revenue of $14.1 million (likely from grants or collaboration revenue; no product revenue yet) ([linkedin.com](https://linkedin.com/company/rezolute))
- **Notable Investors/Partners**: Not publicly available – company is publicly traded and does not disclose a lead investor list. Key partners include clinical trial sites and regulatory agencies (FDA, EMA).
- **Growth Signals**:
  - Headcount: 50 employees (+2.9% YoY) ([linkedin.com](https://linkedin.com/company/rezolute))
  - Phase 3 sunRIZE study fully enrolled; topline data pending December 2025.
  - Phase 3 upLIFT study enrolling with streamlined design; data expected second half 2026.
  - FDA granted Breakthrough Therapy Designation for tumor HI in May 2025.
  - Multiple regulatory designations accelerating development pathway.

## Competitive Advantages
- **Unique mechanism**: Ersodetug acts downstream from beta cells at the insulin receptor, allowing it to potentially treat all forms of hyperinsulinism (genetic or acquired) regardless of underlying cause.
- **Dosing convenience**: Half‑life >2 weeks enables monthly intravenous administration.
- **Regulatory momentum**: Orphan Drug, Rare Pediatric Disease, Breakthrough Therapy, PRIME, and ILAP designations provide expedited review, potential priority review voucher, and closer FDA/EMA collaboration.
- **Pivotal data catalysts**: Two Phase 3 studies read out within ~12‑18 months, creating clear value inflection points.

## Strategic Focus
- Execute the two ongoing Phase 3 trials (sunRIZE in congenital HI, upLIFT in tumor HI).
- Assuming positive topline data from sunRIZE, submit a Biologics License Application (BLA) to the FDA for ersodetug in mid‑2026.
- Continue to build commercial and medical affairs infrastructure (recent job postings indicate hires in Commercial Operations, Marketing, Payer Strategy, and Supply Chain) ([rezolutebio.com – Job Openings](https://rezolutebio.com/job-openings/)).

## Why Work Here
- **Mission‑driven**: Employees work on therapies for ultra‑rare, life‑threatening conditions with high unmet medical need.
- **Benefits**: Comprehensive health/dental/vision insurance, competitive salaries, annual bonus, 401(k) with company match, tuition assistance, on‑site meals, flexible spending accounts ([rezolutebio.com – Benefits](https://rezolutebio.com/job-openings/)).
- **Work environment**: Hybrid/office policy not explicitly stated; roles are based in Redwood City (HQ) and Louisville. Recent openings include remote-friendly functions? Not confirmed.
- **Growth opportunity**: Small company (~50 people) entering late‑stage development and pre‑commercial build‑out – employees can have broad impact and career advancement.
- **Engineering culture**: For biotech, the focus is on clinical operations, regulatory, and commercial roles rather than traditional engineering. IT positions (Business System Engineer) exist.

## Sources
1. [linkedin.com – Rezolute company page](https://linkedin.com/company/rezolute)
2. [rezolutebio.com – Job Openings & Benefits](https://rezolutebio.com/job-openings/)
3. [ir.rezolutebio.com – SEC 10-K Filing (September 2025)](https://ir.rezolutebio.com/sec-filings/content/0001104659-25-090848/0001104659-25-090848.pdf)
4. [rezolutebio.com – Leadership page](https://rezolutebio.com/leadership/)

## Other roles at Rezolute

- [Director – Biostatistics](https://feeny.ai/job/director-biostatistics-rezolute-redwood-city-rsdg74z82vkk) — Redwood City, CA
- [Medical Science Liaison / Senior Medical Science Liaison - Oncology / Rare Endocrine Disorders](https://feeny.ai/job/medical-science-liaison-senior-medical-science-liaison-oncology-rare-endocrine-bhs2782j7gtm)
- [Medical Science Liaison / Senior Medical Science Liaison - Pediatric Endocrinology / Rare Metabolic Disorders](https://feeny.ai/job/medical-science-liaison-senior-medical-science-liaison-pediatric-endocrinology-pvkvqb4szfae)
- [Recruiting Coordinator & Scheduler – 6 month contract](https://feeny.ai/job/recruiting-coordinator-scheduler-6-month-contract-rezolute-redwood-city-x0gcanx9q7vf) — Redwood City, CA
- [Contract Recruiter (Biopharmaceutical Industry) 6 month contract](https://feeny.ai/job/contract-recruiter-biopharmaceutical-industry-6-month-contract-rezolute-redwood-jvpc3bn5g8t2) — Redwood City, CA
- [Head of Product Launch Program Management (Rare Disease)](https://feeny.ai/job/head-of-product-launch-program-management-rare-disease-rezolute-redwood-city-7qka6sahvk1h) — Redwood City, CA
- [Associate Director, Medical Affairs Operations](https://feeny.ai/job/associate-director-medical-affairs-operations-rezolute-redwood-city-gg2p7j75sszn) — Redwood City, CA
- [Vice President, Global Manufacturing](https://feeny.ai/job/vice-president-global-manufacturing-rezolute-redwood-city-wcyqhfyet1yw) — Redwood City, CA
- [Vice President, Global Supply Chain](https://feeny.ai/job/vice-president-global-supply-chain-rezolute-redwood-city-q0dngx787mdk) — Redwood City, CA
- [Medical Writer II, Clinical/Regulatory](https://feeny.ai/job/medical-writer-ii-clinical-regulatory-rezolute-redwood-city-h43j74mshd1b) — Redwood City, CA